HI
BIIB icon

Human Investing’s Biogen BIIB Stock Holding History

Human Investing’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-420
Closed -$103K – 302
2020
Q4 		$103K Sell
420
-10
-2% -$2.58K 0.03% 138
2020
Q3 		$122K Hold
430
– – 0.04% 114
2020
Q2 		$115K Hold
430
– – 0.04% 119
2020
Q1 		$136K Sell
430
-252
-37% -$76.5K 0.06% 100
2019
Q4 		$202K Hold
682
– – 0.07% 113
2019
Q3 		$159K Buy
682
+247
+57% +$57.5K 0.06% 120
2019
Q2 		$102K Buy
435
+89
+26% +$20.6K 0.04% 153
2019
Q1 		$82K Buy
346
+11
+3% +$3.46K 0.03% 163
2018
Q4 		$101K Buy
+335
New +$107K 0.04% 150

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Human Investing's BIIB Position: Q1 2021 in Review

Human Investing sold out of Biogen (BIIB) in Q1 2021, closing a stake of 420 shares — an estimated $103K sold.

Human Investing first reported a position in BIIB in Q4 2018 and held it in 9 quarters. The position peaked at $202K in Q4 2019. 1,094 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • Human Investing reported no remaining Biogen position as of Q1 2021 after selling out during the quarter.
  • Human Investing sold 420 Biogen shares in Q1 2021, an estimated $103K.
  • Human Investing first reported a position in Biogen in Q4 2018 and held it in 9 quarters.
  • Human Investing's Biogen position peaked at $202K in Q4 2019.
  • 1,094 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on Human Investing's 13F filing for Q1 2021, filed 5 May 2021.